(UroToday.com) The treatment for metastatic hormone-sensitive prostate cancer plenary session at the European Association of Urology 2021 Virtual Meeting included a presentation by Dr. Pierre Blanchard discussing the role of imaging-guided treatment for recurrent metastatic hormone-sensitive prostate cancer (mHSPC).